Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets (Parenthetical)

v3.20.1
Consolidated Balance Sheets (Parenthetical) - USD ($)
Mar. 31, 2020
Mar. 31, 2019
Statement of Financial Position [Abstract]    
Accounts receivable, allowances $ 4,059,000 $ 895,000
Short term debt, issuance costs 62,000 0
Long term debt, issuance costs and discounts $ 245,000 $ 0
Series A convertible preferred stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Series A convertible preferred stock, shares authorized (in shares) 2,000,000 2,000,000
Series A convertible preferred stock, shares issued (in shares) 100,000 100,000
Series A convertible preferred stock, shares outstanding (in shares) 100,000 100,000
Series A convertible preferred stock, liquidation preference $ 1,000,000 $ 1,000,000
Common stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Common stock, authorized (in shares) 200,000,000 200,000,000
Common stock, issued (in shares) 88,041,240 82,354,940
Common stock, outstanding (in shares) 87,306,784 81,620,485
Treasury Stock (in shares) 754,599 754,599